-
Mercator MedSystems Inc., San Leandro, Calif. Business: Drug delivery Appointed: Joel Kanter, president of Windy City Inc.; Ned Scheetz, founder of Aphelion Capital; and Doug Wall, partner at Volcano Capital
Published on 6/10/2013
-
Mirna Therapeutics Inc., Austin, Texas Business: Cancer Hired: Sinil Kim as VP of oncology and CMO, formerly senior director at Pfizer Inc.
Published on 6/10/2013
-
Oxford BioMedica plc (LSE:OXB), Oxford, U.K. Business: Cancer, Gene/Cell therapy, Neurology Departing: Stuart Naylor as CSO and a director Hired: Madhu Davies, an Oxford BioMedica consultant, as CMO, a newly created …
Published on 6/10/2013
-
Protagonist Therapeutics Inc., Redwood City, Calif. Business: Infectious, Cancer Appointed: Asish Xavier, vice president of venture investments at Johnson & Johnson Development Corp.
Published on 6/10/2013
-
Protagonist Therapeutics Inc., Redwood City, Calif. Business: Infectious, Cancer Hired: David Liu as CSO, formerly COO of Trenovus Inc.
Published on 6/10/2013
-
PTC Therapeutics Inc., South Plainfield, N.J. Business: Pulmonary, Cancer, Infectious Hired: Shane Kovacs as CFO, formerly managing director of health care investment banking at Credit Suisse
Published on 6/10/2013
-
Sinovac Biotech Ltd. (NASDAQ:SVA), Beijing, China Business: Infectious Transitioned: VP Nan Wang to CFO; she succeeds Danny Chung, who resigned
Published on 6/10/2013
-
Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI), Henderson, Nev. Business: Cancer Hired: Kurt Gustafson as EVP, principal accounting officer, and CFO, formerly VP and CFO at Halozyme Therapeutics Inc. Transitioned: Brett …
Published on 6/10/2013
-
SQI Diagnostics Inc. (TSX-V:SQD), Toronto, Ontario Business: Diagnostic Appointed: Claude Ricks as chairman; he replaces Eric Schneider, who remains a director
Published on 6/10/2013
-
SQI Diagnostics Inc. (TSX-V:SQD), Toronto, Ontario Business: Diagnostic Promoted: Andrew Morris to president and CEO from CFO, effective June 17; he replaces Claude Ricks, who was promoted to chairman
Published on 6/10/2013
-
T2 Biosystems Inc., Lexington, Mass. Business: Diagnostic Hired: Marc Jones as CFO, formerly CFO of Crashlytics Inc., which Twitter Inc. acquired
Published on 6/10/2013
-
Trius Therapeutics Inc. (NASDAQ:TSRX), San Diego, Calif. Business: Infectious Hired: Matthew Onaitis as general counsel and secretary, a newly created position, formerly SVP, general counsel and secretary of Somaxon …
Published on 6/10/2013
-
Verastem Inc. (NASDAQ:VSTM), Cambridge, Mass. Business: Cancer Transitioning: COO Robert Forrester to CEO and a director while remaining president, effective July 1; he succeeds Chairman and CEO Christoph Westphal, who …
Published on 6/10/2013
-
Ziopharm Oncology Inc. (NASDAQ:ZIOP), New York, N.Y. Business: Cancer Departed: Jason Amello as EVP, treasurer and CFO Transitioned: Kevin Lafond to VP of finance, treasurer, principal financial officer and chief …
Published on 6/10/2013
-
Achillion Pharmaceuticals Inc. (NASDAQ:ACHN), New Haven, Conn. Business: Infectious Transitioned: President of R&D and CSO Milind Deshpande to president, CEO and a director; he succeeds Michael Kishbauch, who remains a …
Published on 6/3/2013
-
Atopix Therapeutics Ltd., London, U.K. Business: Dermatology Appointed: Mike Carter, venture partner at SV Life Sciences; Luke Evnin, managing director at MPM Capital; and Regina Hodits, general partner at Wellington …
Published on 6/3/2013
-
BioInvent International AB (SSE:BINV), Lund, Sweden Business: Cardiovascular, Cancer, Antibodies Hired: Michael Oredsson as president and CEO, effective within six months, formerly CEO of Probi AB
Published on 6/3/2013
-
Daiichi Sankyo Co. Ltd. (Tokyo:4568; Osaka:4568), Tokyo, Japan Business: Pharmaceuticals Promoted: Gideon Bollag to CEO of Daiichi's Plexxikon Inc. subsidiary from SVP of research; he replaces Peter Hirth, who retired; …
Published on 6/3/2013
-
Kala Pharmaceuticals Inc., Waltham, Mass. Business: Ophthalmic, Drug delivery Hired: Charles McDermott as EVP of business development, formerly VP of business development for eye care and drug delivery at Allergan Inc.
Published on 6/3/2013
-
Ophthotech Corp., New York, N.Y. Business: Ophthalmic Transitioned: Samir Patel to vice chairman while remaining president
Published on 6/3/2013
-
Ophthotech Corp., New York, N.Y. Business: Ophthalmic Transitioned: Chairman David Guyer to CEO
Published on 6/3/2013
-
Probi AB (SSE:PROB), Lund, Sweden Business: Nutraceuticals Transitioning: VP of R&D Gun-Britt Fransson to interim CEO; she replaces Michael Oredsson, who is departing
Published on 6/3/2013
-
Silence Therapeutics plc (LSE:SLN), London, U.K. Business: Cancer, Renal, Ophthalmic Promoted: Ali Mortazavi to CEO from director of corporate strategy; he is replaced by Annie Cheng, formerly a strategy consultant for …
Published on 6/3/2013
-
Simcere Pharmaceutical Group (NYSE:SCR), Nanjing, China Business: Cancer, Generics Resigned: Peng Wang as CSO, for personal reasons
Published on 6/3/2013
-
Singulex Inc., Alameda, Calif. Business: Diagnostic, Supply/Service Transitioned: Guido Baechler to president, CEO and a director from SVP of operations; he succeeds Philippe Goix, who departed
Published on 6/3/2013